124 related articles for article (PubMed ID: 22683670)
1. NFκB pathway is down-regulated by 1α,25(OH)(2)-vitamin D(3) in endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein coupled receptor.
Gonzalez-Pardo V; D'Elia N; Verstuyf A; Boland R; Russo de Boland A
Steroids; 2012 Sep; 77(11):1025-32. PubMed ID: 22683670
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D analogue TX 527 down-regulates the NF-κB pathway and controls the proliferation of endothelial cells transformed by Kaposi sarcoma herpesvirus.
González-Pardo V; Verstuyf A; Boland R; Russo de Boland A
Br J Pharmacol; 2013 Aug; 169(7):1635-45. PubMed ID: 23647513
[TBL] [Abstract][Full Text] [Related]
3. 1 Alpha,25-dihydroxyvitamin D3 and its TX527 analog inhibit the growth of endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein-coupled receptor in vitro and in vivo.
Gonzalez-Pardo V; Martin D; Gutkind JS; Verstuyf A; Bouillon R; de Boland AR; Boland RL
Endocrinology; 2010 Jan; 151(1):23-31. PubMed ID: 19915163
[TBL] [Abstract][Full Text] [Related]
4. The proapoptotic protein Bim is up regulated by 1α,25-dihydroxyvitamin D3 and its receptor agonist in endothelial cells and transformed by viral GPCR associated to Kaposi sarcoma.
Suares A; Russo de Boland A; Verstuyf A; Boland R; González-Pardo V
Steroids; 2015 Oct; 102():85-91. PubMed ID: 26254608
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle arrest and apoptosis induced by 1α,25(OH)2D3 and TX 527 in Kaposi sarcoma is VDR dependent.
González-Pardo V; Suares A; Verstuyf A; De Clercq P; Boland R; de Boland AR
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():197-200. PubMed ID: 24316429
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic effect of 1α,25(OH)
Suares A; Tapia C; González-Pardo V
J Steroid Biochem Mol Biol; 2019 Feb; 186():122-129. PubMed ID: 30308321
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels.
Cohen-Lahav M; Shany S; Tobvin D; Chaimovitz C; Douvdevani A
Nephrol Dial Transplant; 2006 Apr; 21(4):889-97. PubMed ID: 16455676
[TBL] [Abstract][Full Text] [Related]
8. 1α,25(OH)
Tapia C; Principe G; González-Pardo V
Biochimie; 2023 Sep; 212():76-84. PubMed ID: 37062469
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effects of Bortezomib in endothelial cells transformed by viral G protein-coupled receptor associated to Kaposi's sarcoma.
Suares A; Mori Sequeiros Garcia M; Paz C; González-Pardo V
Cell Signal; 2017 Apr; 32():124-132. PubMed ID: 28161489
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma.
Bu R; Hussain AR; Al-Obaisi KA; Ahmed M; Uddin S; Al-Kuraya KS
Leuk Lymphoma; 2014 Feb; 55(2):415-24. PubMed ID: 23697845
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages.
Cohen-Lahav M; Douvdevani A; Chaimovitz C; Shany S
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):558-62. PubMed ID: 17267205
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-dihydroxyvitamin D3 stimulates phosphorylation of IkappaBalpha and synergizes with TPA to induce nuclear translocation of NFkappaB during monocytic differentiation of NB4 leukemia cells.
Berry DM; Clark CS; Meckling-Gill KA
Exp Cell Res; 2002 Jan; 272(2):176-84. PubMed ID: 11777342
[TBL] [Abstract][Full Text] [Related]
13. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
14. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of COX-2 activity by 1α,25(OH)
Tapia C; Zamarreño F; Salvador GA; Casali CI; Viso J; Fernandez MDC; White JH; González-Pardo V
Heliyon; 2020 Oct; 6(10):e05149. PubMed ID: 33072916
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells.
Tamatani T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Fujisawa K; Nagai H; Miyamoto Y
Int J Oncol; 2013 Mar; 42(3):935-44. PubMed ID: 23340716
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease.
Suzuki Y; Ichiyama T; Ohsaki A; Hasegawa S; Shiraishi M; Furukawa S
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):134-8. PubMed ID: 19138739
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
[TBL] [Abstract][Full Text] [Related]
19. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor.
Sun J; Kong J; Duan Y; Szeto FL; Liao A; Madara JL; Li YC
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E315-22. PubMed ID: 16507601
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D(3) in human prostate cells.
Munetsuna E; Nakabayashi S; Kawanami R; Yasuda K; Ohta M; Arai MA; Kittaka A; Chen TC; Kamakura M; Ikushiro S; Sakaki T
J Mol Endocrinol; 2011 Oct; 47(2):209-18. PubMed ID: 21693624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
